CClinicalTrials.gg
Active, not recruitingNCT06288048Updated Mar 1, 2024

Effect of Mirror Therapy on Post-Needling Pain Following Deep Dry Needling of Myofascial Trigger Point in Lateral Elbow Pain

A Phase 2/3 interventional study of Experimental: Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching + MFT and Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching in Lateral Elbow Pain, sponsored by Universidad Europea de Canarias. Active, not recruiting at 1 site in Spain. Per ClinicalTrials.gov, last updated 2024-03-01.

Sponsored by Universidad Europea de Canarias · Phase 2/3, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Mar 2024, 2 years 7 months ago, but the record still lists the study as active, not recruiting.
  • Registered 10 months after the study started (first participant enrolled Apr 2023, registered Feb 2024).
Phase
Phase 2/3
Study type
Interventional
Enrollment
49
Allocation
Randomized
Sex
All
01

Study summary

The goal of this randomized, controlled pilot trial is to investigate the immediate effects of incorporating Mirror Visual Feedback Therapy (MFT) on pain sensitivity and motor performance in individuals experiencing Post-needling pain associated with lateral elbow pain. The main questions it aims to answer are:

  • Does incorporating Mirror Visual Feedback Therapy reduce Post-needling pain intensity?
  • Does incorporating Mirror Visual Feedback Therapy improve pressure pain threshold?
  • Does incorporating Mirror Visual Feedback Therapy improve maximum grip strenght?

Participants will be asked to undergo pre- and post-treatment evaluations, which include assessments of Post-needling pain intensity, pressure pain threshold, two-point discrimination threshold, and maximum hand grip strength.

Participants in the Experimental Group will receive Deep Dry Needling in the m. Brachioradialis, Ischemic Compression, Cold Spray, Stretching, and Mirror Visual Feedback Therapy. Those in the Control Group will not receive Mirror Visual Feedback Therapy.

Researchers will compare the Experimental Group to the Control Group to see if the incorporation of Mirror Visual Feedback Therapy results in a reduction in Post-needling pain intensity and improvement in pressure pain threshold.

Read the detailed description

This randomized, controlled pilot trial aims to investigate the immediate effects of incorporating Mirror Visual Feedback Therapy (MFT) on pain sensitivity and motor performance in individuals experiencing Post-needling pain associated with lateral elbow pain. The study will enroll a total of 49 participants, with 23 females and 26 males, who will be randomly allocated to either the Experimental Group or the Control Group. The Experimental Group will receive Deep Dry Needling in the m. Brachioradialis, Ischemic Compression, Cold Spray, Stretching, and Mirror Visual Feedback Therapy, while the Control Group will not receive Mirror Visual Feedback Therapy. This random allocation is intended to minimize bias and enhance the internal validity of the study.

Pre- and post-treatment evaluations will include assessments of Post-needling pain intensity, pressure pain threshold, two-point discrimination threshold, and maximum hand grip strength. Intergroup analysis will be conducted to determine if there is a statistically significant reduction in Post-needling pain intensity favoring the Experimental Group. Additionally, intragroup analysis will assess whether there are significant improvements in pressure pain threshold solely within the Experimental Group following the intervention.

The findings of this study may suggest a potential benefit of integrating MFT into treatment protocols for individuals with lateral elbow pain experiencing Post-needling discomfort. However, further research will be necessary to fully elucidate the clinical implications of these findings and their applicability in healthcare settings.

02

Conditions studied

  • Lateral Elbow Pain

Keywords

  • Mirror Therapy; Dry Needling; Post-Needling Pain; Myofascial Trigger Point
03

In context

Lead sponsor

Universidad Europea de Canarias is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Individuals males and females aged 18 years or older
  • Individuals suffering from lateral elbow myofascial pain diagnosed by either a GP or physical therapist
  • for less than 3 months
  • lacking a history of severe trauma
  • Individuals not having any prior exposure to Dry Needling treatment
  • Individuals not currently using relevant medications

Exclusion criteria

Exclusion Criteria:

  • Individuals under the age of 18
  • Individuals not diagnosed with lateral elbow myofascial pain by either a GP or physical therapist
  • Individuals experiencing lateral elbow myofascial pain for more than 3 months
  • Individuals with a history of severe trauma to the affected area
  • Individuals who have previously undergone Dry Needling treatment for their lateral elbow myofascial pain
  • Individuals currently using medications relevant to the treatment of lateral elbow myofascial pain
05

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
49 participants (estimated)

Study arms

  • Experimental
    Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching + MFT

    The intervention protocol in this study will target individuals experiencing Post-needling pain associated with lateral elbow pain. It will comprise a series of treatments including Deep Dry Needling (DDN) focused on the proximal third of the m. Brachioradialis (BR), was conducted with the patient seated and the therapist positioned on the same side as the needle insertion. Following DDN, ischemic compression (IC) will be applied using a sphygmomanometer on the seated subject's arm, along with three applications of cold spray synchronized with m. Brachioradialis (BR) stretching. The intervention will conclude with Mirror Therapy (MFT), where the patient will face a mirror covering the punctured side at a 45-degree angle for proper hand visualization, engaging in hand exercises and wrist movements while observing their reflection.

    Procedure: Experimental: Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching + MFT

  • Active comparator
    Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching

    The intervention protocol in this study will target individuals experiencing Post-needling pain associated with lateral elbow pain. It will comprise a series of treatments including Deep Dry Needling (DDN) focused on the proximal third of the m. Brachioradialis (BR), conducted with the patient seated and the therapist positioned on the same side as the needle insertion. Following DDN, ischemic compression (IC) will be applied using a sphygmomanometer on the seated subject's arm, along with three applications of cold spray synchronized with m. Brachioradialis (BR) stretching. The intervention will not conclude with Mirror Therapy (MFT).

    Procedure: Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching

Interventions

  • ProcedureExperimental: Deep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching + MFT

    Experimental: Target: Proximal third of m. Brachioradialis (BR) Patient position: Seated Therapist position: Same side as needle insertion Needle insertion direction: Lateral-to-medial towards clinician\'s finger Needle type: AguPunt® Barcelona, Spain Technique: Seek three local twitch responses in m. Brachioradialis (BR) Alternative for no responses: 10 needle insertions and withdrawals at 1 Hz frequency Ischemic Compression (IC): Applied using sphygmomanometer on seated subject\'s arm Pressure: Increased until ischemic pain (approx. 200 mmHg) Duration: Maintained for 90 seconds Combined with three applications of Cryos Phyto Performance 400 ml cold spray synchronized with m. Brachioradialis (BR) stretching: Stretching: Passive sustained mobilization with elbow extension and forearm pronation for 10 seconds Mirror Therapy (MFT): Setup: Patient seated with forearms resting on bed Mirror: 35 x 35 cm, covering punctured side at 45-degree angle for hand visualization

  • ProcedureDeep Dry Needling (DDN), Ischemic Compression, Cold Spray with Stretching

    The intervention protocol in this study will target individuals experiencing Post-needling pain associated with lateral elbow pain. It will comprise a series of treatments including Deep Dry Needling (DDN) focused on the proximal third of the m. Brachioradialis (BR), conducted with the patient seated and the therapist positioned on the same side as the needle insertion. Following DDN, ischemic compression (IC) will be applied using a sphygmomanometer on the seated subject\'s arm, along with three applications of cold spray synchronized with m. Brachioradialis (BR) stretching. The intervention will not conclude with Mirror Therapy (MFT).

06

What researchers measure

Primary outcomes

  1. Pain Intensity

    Pain intensity refers to the subjective level of discomfort or suffering experienced by an individual due to pain. It will be measured in Visual Analogue Scale (VAS).

    Time frame: From before and after the intervention until the conclusion of treatment at the 1-hour.

  2. Pain pressure threshold

    The pain pressure threshold refers to the amount of pressure or force applied to a specific area of the body before the sensation of pain is experienced. It is commonly used in medical evaluations to assess pain sensitivity and tolerance. It will be measured in PPT (Kg/cm2)

    Time frame: From before and after the intervention until the conclusion of treatment at the 1-hour.

  3. Two-point discrimination threshold

    The two-point discrimination threshold refers to the ability of an individual to perceive two separate points of contact on the skin as distinct from a single point. It will be measured in 2-point discriminator 12-1480 skin caliper Baseline®.

    Time frame: From before and after the intervention until the conclusion of treatment at the 1-hour.

  4. Maximum hand grip strength

    Maximum hand grip strength refers to the maximum force that an individual can exert when squeezing an object with their hand muscles. It will be measured JAMAR® Hand Dynamometer J00105.

    Time frame: From before and after the intervention until the conclusion of treatment at the 1-hour.

07

Study locations

1 site
  • Universidad Europea de Canarias
    La Orotava, Santa Cruz De Tenerife 38300, Spain
08

References and documents

Publications

  • Martin-Pintado-Zugasti A, Mayoral Del Moral O, Gerwin RD, Fernandez-Carnero J. Post-needling soreness after myofascial trigger point dry needling: Current status and future research. J Bodyw Mov Ther. 2018 Oct;22(4):941-946. doi: 10.1016/j.jbmt.2018.01.003. Epub 2018 Jan 17. PubMed 30368339 ↗

Individual participant data

Plan to share: No — Results should not be shared, although they will be available to reviewers upon request.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 1, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06288048
Lead sponsor
Universidad Europea de Canarias
Responsible party
Sebastian Eustaquio Martin Perez (Full-Time Professor, Universidad Europea de Canarias) — Principal investigator
First posted
Mar 1, 2024
Start date
Apr 1, 2023
Primary completion
Mar 7, 2024 (estimated)
Completion
Jun 30, 2024 (estimated)
Last update
Mar 1, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion